Insider Trading Alert - ARE, LPS, UTHR, GCO And GWRE Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 23, 2013, 95 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $477.16 to $45,000,060.00.

Highlighted Stocks Traded by Insiders:

Alexandria Real Estate Equities (ARE) - FREE Research Report

Moglia Peter M who is Chief Investment Officer at Alexandria Real Estate Equities sold 3,000 shares at $63.83 on Dec. 23, 2013. Following this transaction, the Chief Investment Officer owned 42,166 shares meaning that the stake was reduced by 6.64% with the 3,000-share transaction.

The shares most recently traded at $64.39, up $0.56, or 0.87% since the insider transaction. Historical insider transactions for Alexandria Real Estate Equities go as follows:

  • 12-Week # shares sold: 5,000
  • 24-Week # shares sold: 19,000

The average volume for Alexandria Real Estate Equities has been 426,800 shares per day over the past 30 days. Alexandria Real Estate Equities has a market cap of $4.6 billion and is part of the financial sector and real estate industry. Shares are down 7.36% year-to-date as of the close of trading on Monday.

Alexandria Real Estate Equities, Inc., a real estate investment trust (REIT), engages in the ownership, operation, management, development, acquisition, and redevelopment of properties for the life sciences industry. The stock currently has a dividend yield of 4.24%. The company has a P/E ratio of 44.3. Currently there are 4 analysts that rate Alexandria Real Estate Equities a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ARE - FREE

TheStreet Quant Ratings rates Alexandria Real Estate Equities as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income, good cash flow from operations, impressive record of earnings per share growth and notable return on equity. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Alexandria Real Estate Equities Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Lender Processing Services (LPS) - FREE Research Report

Carpenter Alvin R who is Director at Lender Processing Services sold 28,931 shares at $36.38 on Dec. 23, 2013. Following this transaction, the Director owned 11,542 shares meaning that the stake was reduced by 71.48% with the 28,931-share transaction.

Hunt David K who is Director at Lender Processing Services sold 2,735 shares at $36.42 on Dec. 23, 2013. Following this transaction, the Director owned 19,741 shares meaning that the stake was reduced by 12.17% with the 2,735-share transaction.

The shares most recently traded at $37.27, up $0.85, or 2.28% since the insider transaction. Historical insider transactions for Lender Processing Services go as follows:

  • 4-Week # shares sold: 65,254
  • 12-Week # shares sold: 248,598
  • 24-Week # shares sold: 248,598

The average volume for Lender Processing Services has been 922,600 shares per day over the past 30 days. Lender Processing Services has a market cap of $3.1 billion and is part of the services sector and diversified services industry. Shares are up 50.49% year-to-date as of the close of trading on Monday.

Lender Processing Services, Inc. provides integrated technology, data, and services to the mortgage lending industry in the United States. The company operates in two segments, Technology, Data, and Analytics; and Transaction Services. The stock currently has a dividend yield of 1.1%. The company has a P/E ratio of 27.0. Currently there are no analysts that rate Lender Processing Services a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LPS - FREE

TheStreet Quant Ratings rates Lender Processing Services as a buy. The company's strengths can be seen in multiple areas, such as its good cash flow from operations, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Lender Processing Services Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

United Therapeutics Corporation (UTHR) - FREE Research Report

Rothblatt Martine A who is Ceo at United Therapeutics Corporation sold 18,149 shares at $109.85 on Dec. 23, 2013. Following this transaction, the Ceo owned 630,333 shares meaning that the stake was reduced by 2.8% with the 18,149-share transaction.

The shares most recently traded at $113.90, up $4.05, or 3.55% since the insider transaction. Historical insider transactions for United Therapeutics Corporation go as follows:

  • 24-Week # shares sold: 1,000

The average volume for United Therapeutics Corporation has been 574,900 shares per day over the past 30 days. United Therapeutics Corporation has a market cap of $4.4 billion and is part of the health care sector and drugs industry. Shares are up 114.36% year-to-date as of the close of trading on Monday.

United Therapeutics Corporation, a biotechnology company, focuses on the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide. The company has a P/E ratio of 16.0. Currently there are 3 analysts that rate United Therapeutics Corporation a buy, 1 analyst rates it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UTHR - FREE

TheStreet Quant Ratings rates United Therapeutics Corporation as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, solid stock price performance and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full United Therapeutics Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Genesco (GCO) - FREE Research Report

Caplan Jonathan D who is Sr Vice President at Genesco sold 10,000 shares at $72.58 on Dec. 23, 2013. Following this transaction, the Sr Vice President owned 64,948 shares meaning that the stake was reduced by 13.34% with the 10,000-share transaction.

The shares most recently traded at $72.36, down $0.22, or 0.3% since the insider transaction. Historical insider transactions for Genesco go as follows:

  • 4-Week # shares sold: 69,016
  • 12-Week # shares sold: 69,016
  • 24-Week # shares sold: 77,016

The average volume for Genesco has been 202,200 shares per day over the past 30 days. Genesco has a market cap of $1.7 billion and is part of the services sector and retail industry. Shares are up 32.96% year-to-date as of the close of trading on Monday.

Genesco Inc. engages in the retail and wholesale of footwear, apparel, and accessories. The company operates in five segments: Journeys Group, Schuh Group, Lids Sports Group, Johnston & Murphy Group, and Licensed Brands. The company has a P/E ratio of 19.8. Currently there are 3 analysts that rate Genesco a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GCO - FREE

TheStreet Quant Ratings rates Genesco as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, attractive valuation levels, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Genesco Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Guidewire Software (GWRE) - FREE Research Report

Blasing Karen who is Chief Financial Officer at Guidewire Software sold 1,106 shares at $45.96 on Dec. 23, 2013. Following this transaction, the Chief Financial Officer owned 1,794 shares meaning that the stake was reduced by 38.14% with the 1,106-share transaction.

Naddaff Alexander C who is VP, Professional Services at Guidewire Software sold 4,816 shares at $45.98 on Dec. 23, 2013. Following this transaction, the VP, Professional Services owned 1,927 shares meaning that the stake was reduced by 71.42% with the 4,816-share transaction.

The shares most recently traded at $48.22, up $2.24, or 4.64% since the insider transaction. Historical insider transactions for Guidewire Software go as follows:

  • 4-Week # shares sold: 177,009
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 266,764
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 565,397

The average volume for Guidewire Software has been 626,400 shares per day over the past 30 days. Guidewire Software has a market cap of $3.2 billion and is part of the technology sector and computer software & services industry. Shares are up 62.55% year-to-date as of the close of trading on Monday.

Guidewire Software, Inc. provides system software to the property and casualty (P&C) insurance industry primarily in the United States, Canada, Australia, the United Kingdom, and internationally. The company has a P/E ratio of 805.2. Currently there are 3 analysts that rate Guidewire Software a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on GWRE - FREE

TheStreet Quant Ratings rates Guidewire Software as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full Guidewire Software Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Global Stocks Slide as Trump's New Trade War Salvo Ignites Fresh Concern

Global Stocks Slide as Trump's New Trade War Salvo Ignites Fresh Concern

Ackman Investment Buoys Lowe's; DraftKings Responds to FanDuel Merger -- ICYMI

Ackman Investment Buoys Lowe's; DraftKings Responds to FanDuel Merger -- ICYMI

Replay: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Replay: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Red Robin Slumps After Earnings Miss

Red Robin Slumps After Earnings Miss